https://www.foxbusiness.com/markets/novo-nordisk-revises-up-offer-for-ablynx-to-3-1-billion
Novo Nordisk revises up offer for Ablynx to $3.1 billion | Fox Business
Danish drugmaker Novo Nordisk has revised up its offer for Belgian biotech company Ablynx as it looks to find growth opportunities beyond its core business.
https://www.biospace.com/ablynx-announces-launch-of-proposed-global-offering
Ablynx Announces Launch Of Proposed Global Offering - BioSpace
Oct 17, 2017 - Ablynx intends to offer and sell, subject to market and other conditions, approximately $175 million of its ordinary shares in a global offering.
global offeringablynxannounceslaunchproposed
https://www.businesswire.com/news/home/20210715005392/en/LabGenius-Announces-Research-Collaboration-With-Ablynx-a-Sanofi-Company
LabGenius Announces Research Collaboration With Ablynx, a Sanofi Company
LabGenius partners with Ablynx, a Sanofi company, to help drive transformative research in inflammatory disease.
research collaborationannouncesablynxsanoficompany
https://www.biospace.com/ablynx-announces-full-exercise-of-underwriters-option-to-purchase-additional-shares-and-end-of-stabilization-period
Ablynx Announces Full Exercise of Underwriters' Option to Purchase Additional Shares and End of...
Oct 27, 2017 - The exercise of the greenshoe option also marks the end of the stabilization period in relation to the initial U.S. public offering.
https://www.fiercebiotech.com/keyword/ablynx
Ablynx | Fierce Biotech
ablynxfiercebiotech
https://www.epo.org/fr/boards-of-appeal/decisions/t221019eu1
T 1019/22 (Bispecific nanobodies/ABLYNX) du 20.02.2024
du 20101922nanobodiesablynx